XHKG
2225
Market cap929mUSD
Feb 13, Last price
1.41HKD
Name
Jinhai International Group Holdings Ltd
Chart & performance
P/E
—
P/S
25.67
EPS
—
Vol. 1Y
—
Shs. 5Y
33.50%
Rev. 5Y
15.54%
Div Yld LY
—
Div Yld TTM
—
Revenues
46m
-7.89%
Net income
-17m
L-4.93%
CFO
-6m
L+86.92%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jinhai Medical Technology Ltd. specializes in offering workforce solutions and a range of complementary support services. Catering primarily to building and construction contractors, their comprehensive service portfolio encompasses dormitory management, warehousing, cleaning operations, and building maintenance. Established in 2006, the firm maintains its corporate headquarters in China.
Key people
Guobao Chen
Chairman of the Board, Executive Director · since 2019
Zhenfei Wang
Chief Executive Officer, Executive Director · since 2019
Fu Kang Yang
Deputy Chairman of the Board, Non-Executive Director · since 2019
Ai Kim Hwa
General Manager, Executive Director · since 2017
Wee How Goh
Head - Sales and Business Development Department · since 2013
Akiko KOSHIISHI
Head - Administrative Department · since 2006
Hong Eng Teo
Dormitory and Transport Manager · since 2008
Man Yiu Wong
Chief Financial Officer, Company Secretary · since 2019
Jiangyu Jiang
Non-Executive Director · since 2019
Yunping Li
Non-Executive Director · since 2019
Huasheng Wang
Non-Executive Director · since 2019
Yimin Fan
Independent Non-Executive Director · since 2019
Kwok Fai Lau
Non-Executive Independent Director · since 2017
Jianjun Yan
Independent Non-Executive Director · since 2019
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||